UBS Group
GUTS icon

UBS Group’s Fractyl Health GUTS Stock Holding History

UBS Group’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$743K Buy
1,622,163
+508,181
+46% +$468K ﹤0.01% 5779
2025
Q4 		$2.45M Buy
1,113,982
+361,386
+48% +$582K ﹤0.01% 4779
2025
Q3 		$1.2M Buy
752,596
+729,754
+3,195% +$947K ﹤0.01% 5412
2025
Q2 		$37K Sell
22,842
-46,843
-67% -$75.7K ﹤0.01% 8023
2025
Q1 		$82.9K Sell
69,685
-23,612
-25% -$37.7K ﹤0.01% 7189
2024
Q4 		$192K Buy
93,297
+77,234
+481% +$180K ﹤0.01% 6475
2024
Q3 		$40.6K Buy
16,063
+12,729
+382% +$41.5K ﹤0.01% 6952
2024
Q2 		$14.2K Buy
+3,334
New +$21.5K ﹤0.01% 7525

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group's GUTS Position: Q1 2026 in Review

UBS Group increased its Fractyl Health (GUTS) stake by 46% in Q1 2026, buying an estimated $468K and bringing the position to 1,622,163 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #5779.

UBS Group first reported a position in GUTS in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.45M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • UBS Group held 1,622,163 shares of Fractyl Health worth $743K as of Q1 2026.
  • UBS Group bought 508,181 Fractyl Health shares in Q1 2026, an estimated $468K.
  • Fractyl Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5779 holding.
  • UBS Group first reported a position in Fractyl Health in Q2 2024 and has held it in 8 quarters since.
  • UBS Group's Fractyl Health position peaked at $2.45M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.